Literature DB >> 15569334

Ethnicity and survival on dialysis in west London.

Shilpanjali Prasad1, Seema Singh, Neill Duncan, Tom D H Cairns, Megan Griffith, Nadey Hakim, Adam G McLean, Andrew Palmer, Vassilios Papalois, David Taube.   

Abstract

BACKGROUND: Indo-Asian and Afro-Caribbean patients have higher rates of renal failure and requirement for renal replacement therapy than the general population in the UK. Despite this, information regarding survival on dialysis is limited.
METHODS: The incident hemodialysis population of a large west London renal service was reviewed from 1996 to 2001 (N = 465).
RESULTS: The cohort's ethnic background was Indo-Asian (30.8%), Caucasian (49%), Afro-Caribbean (18.3%), and other (1.9%). Indo-Asians and Afro-Caribbeans were younger than Caucasian patients, with a higher rate of diabetes mellitus. Survival on hemodialysis for Indo-Asians was 97.5% and 81.6% at 1 and 3 years, respectively, compared with 92.7% and 75.2% for Caucasians, and 97.5% and 85.3% for Afro-Caribbeans (P = nonsignificant). Dialysis adequacy was observed to be associated with survival. Patients with mean single pool Kt/V of over 1.4 had survival of 90.6% and 74.8% at 2 and 5 years, respectively, compared with 74.0% and 42.9% for those with Kt/V less than 1.4 (P < 0.001). There were significantly more patients in the Indo-Asian cohort with a mean Kt/V of 1.4 or over (87.4%) compared with Caucasians (57.6%) and Afro-Caribbeans (52.4%), and the benefit of higher Kt/V was seen in all ethnic groups. In a multivariate analysis of factors including Kt/V over 1.4, age, diabetic status, gender, and ethnicity, Indo-Asian or Afro-Caribbean ethnicity did not confer a survival disadvantage. The strongest predictors of survival were age and dialysis adequacy.
CONCLUSION: Indo-Asian and Afro-Caribbean hemodialysis patients have survival comparable to Caucasians despite a higher burden of diabetes.

Entities:  

Mesh:

Year:  2004        PMID: 15569334     DOI: 10.1111/j.1523-1755.2004.66017.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Why minorities live longer on dialysis: an in-depth examination of the Danish nephrology registry.

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh; Keith C Norris
Journal:  Nephrol Dial Transplant       Date:  2016-01-06       Impact factor: 5.992

2.  The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients.

Authors:  James Fotheringham; Damian G Fogarty; Meguid El Nahas; Michael J Campbell; Ken Farrington
Journal:  Kidney Int       Date:  2015-05-13       Impact factor: 10.612

3.  Identifying depression in South asian patients with end-stage renal disease: considerations for practice.

Authors:  Shivani Sharma; Kamaldeep Bhui; Joseph Chilcot; David Wellsted; Ken Farrington
Journal:  Nephron Extra       Date:  2011-12-28

Review 4.  Disparities in diabetes mellitus among Caribbean populations: a scoping review.

Authors:  Nadia R Bennett; Damian K Francis; Trevor S Ferguson; Anselm J M Hennis; Rainford J Wilks; Eon Nigel Harris; Marlene M Y MacLeish; Louis W Sullivan
Journal:  Int J Equity Health       Date:  2015-02-25

5.  Black ethnicity predicts better survival on dialysis despite greater deprivation and co-morbidity: a UK study.

Authors:  Nicholas Cole; Michael Bedford; Andrew Cai; Chris Jones; Hugh Cairns; Satish Jayawardene
Journal:  Clin Nephrol       Date:  2014-08       Impact factor: 0.975

6.  End stage renal disease in French Guiana (data from R.E.I.N registry): South American or French?

Authors:  Dévi Rita Rochemont; Mohamed Meddeb; Raoul Roura; Cécile Couchoud; Mathieu Nacher; Célia Basurko
Journal:  BMC Nephrol       Date:  2017-06-30       Impact factor: 2.388

7.  Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales.

Authors:  Paul Roderick; Catherine Byrne; Anna Casula; Retha Steenkamp; David Ansell; Richard Burden; Dorothea Nitsch; Terry Feest
Journal:  Nephrol Dial Transplant       Date:  2009-07-21       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.